endocrinology
Type 1 diabetes

Closed loop systems should be available to all ages

Older age is not a barrier to closed-loop therapy, according to Australian research that shows it provides significantly better glucose control than sensor-augmented pump therapy. A Melbourne study randomised 30 adults over 60 years of age and with long-standing type 1 diabetes (mean 38 years) to sensor-augmented pump therapy for 4 months, followed by closed ...

Already a member?

Login to keep reading.


OR
© 2022 the limbic